The ASX healthcare share's price has softened recently, but the long-term investment case remains firmly intact for patient ...

With the ASX 200 near 8,700 points, ResMed Inc. (ASX: RMD) still looks like a quality blue chip stock worth considering.

Resmed Inc () has held its Q3 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for sma ...

Choosing the right CPAP mask can make or break your sleep therapy success. From cushion materials to strap adjustments, small details change comfort and adherence. New designs and clever hacks are ...

Medical device company ResMed (NYSE:RMD) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales ...

Q3 reiterated FY 2026 gross margin range “62% to 63%” (CFO Sandercock), consistent with Q2’s updated FY 2026 gross margin range.

The AirTouch F30i Comfort mask for CPAP. [Image courtesy of Resmed] Resmed (NYSE: RMD) + announced today that it began the launch of its new AirTouch F30i Comfort mask in the U.S. The new continuous ...

Abstract: Vision-based teleoperation systems are widely used due to their cost-effectiveness and intuitive operation. However, these systems often suffer from challenges such as hand occlusions, ...

Resmed is looking to new innovations to give the sleep health company an advantage against its competitors. The company, which makes sleep apnea machines, masks and accessories, highlighted new ...

Hello, and welcome to the Q1 Fiscal Year 2026 ResMed Earnings Conference Call. My name is Kevin. I'll be your operator for today's call. [Operator Instructions] Also, please note, this conference call ...

Sleep health technology firm Resmed has announced the UK launch of its latest innovative CPAP (continuous positive airway pressure) mask to treat sleep apnoea. The AirTouch N30i has been designed to ...